Routine initial ownership filing for a new director. No actionable trading signal — monitor for future Form 4 filings if Schmid acquires or disposes of shares.
Price Chart
Executive Summary
John P. Schmid filed an initial Statement of Beneficial Ownership (Form 3) upon becoming a director of BlossomHill Therapeutics, Inc. The filing reports a grant of 67,620 stock options exercisable at $13.59 per share, expiring May 17, 2036, with no common stock currently held. This is a routine directors' initial ownership disclosure with no trading activity or financial results.
Key Facts
- John P. Schmid filed a Form 3 as a director of BlossomHill Therapeutics, Inc. (BLSM).
- Schmid reported 67,620 stock options (Right to Buy) at an exercise price of $13.59, expiring May 17, 2036.
- No common stock or other securities are reported as beneficially owned.
- The options are immediately exercisable.
- The filing is dated August 6, 2026, and was signed by Vincent Liptak as attorney-in-fact.
Financial Impact
No financial impact — standard director option grant disclosed upon appointment
Risk Factors
- None from this filing — no trading activity or financial data disclosed
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001478916-26-000014 |
| Document: 0001478916-26-000014-index-headers.html | 0001478916-26-000014 |
| Document: 0001478916-26-000014-index.html | 0001478916-26-000014 |
| Document: 0001478916-26-000014.txt | 0001478916-26-000014 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 28, 2026 29d ago | Press Release | $21.34 $16.39 | ▲ +23.20% | ▲ +23.16% | $15.76 (+26.15%) |
Sep 18, 2026 5w ago | 8-K | $25.74 $13.94 | ▲ +45.84% | ▲ +46.05% | $15.76 (+38.77%) |
Sep 18, 2026 5w ago | Press Release | $25.74 $13.94 | ▼ −45.84% | ▼ −46.05% | $15.76 (−38.77%) |
Sep 15, 2026 6w ago | 8-K | $22.17 $15.48 | ▼ −30.18% | ▼ −33.15% | $15.76 (−28.91%) |
Aug 12, 2026 10w ago | Insider Cluster | $16.35 $20.86 | ▲ +27.58% | ▲ +29.33% | $15.76 (−3.61%) |
Aug 10, 2026 11w ago | Insider Cluster | $16.52 $22.00 | ▲ +33.17% | ▲ +34.23% | $15.76 (−4.60%) |
Aug 10, 2026 11w ago | 8-K | $16.52 $22.00 | ▲ +33.17% | ▲ +34.23% | $15.76 (−4.60%) |
Aug 7, 2026 11w ago | 424B4 | $15.99 $22.93 | ▲ +43.40% | ▲ +44.32% | $15.76 (−1.44%) |
Aug 7, 2026 11w ago | EFFECT | $16.00 $22.01 | ▲ +37.56% | ▲ +37.96% | $15.76 (−1.50%) |
Aug 6, 2026 11w ago | 3 | $16.00 $22.01 | ▲ +37.56% | ▲ +37.96% | $15.76 (−1.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers